Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA

Chad J. Achenbach, M. Till, F. J. Palella, Maria Deloria Knoll, S. M. Terp, A. U. Kalnins, R. L. Murphy

Research output: Contribution to journalArticle

Abstract

Objectives: Evaluation of extended treatment interruption (TI) in chronic HIV infection among patients successfully treated with antiretroviral therapy. Methods: An observational analysis of 25 patients in a prospectively followed cohort with chronic HIV infection, viral loads <500 HIV-1 RNA copies/mL for at least 6 months, and an interruption in therapy of ≥ 28 days duration was carried out. Follow up was divided into 3-month time periods for analysis. The effects of time period, stratification group and stratification group by time period interactions on CD4 counts were tested using a mixed model. Univariate comparisons among patient characteristics and responses were performed using Fisher's exact test or the Wilcoxon rank sum test. Results: At initiation of TI, the median CD4 count was 799 cells/μL. TI duration was a median of 7.1 months. HIV RNA rebounded to a median maximum level of 75 000 copies/mL. Maximum viral rebound was significantly greater in patients who were male, had lipodystrophy and had zenith HIV RNA prior to TI of ≥ 50 000 copies/mL. Lower CD4 cell counts were observed during TI in patients with lipodystrophy, zenith HIV RNA ≥ 50 000 copies/mL, history of AIDS, HIV infection ≥ 5 years and presuppression CD4 count ≤ 350 cells/μL. Patients who reinitiated therapy had shorter TI duration, presuppression CD4 count ≤ 350 cells/μL, previous AIDS diagnosis and lipodystrophy. No patients developed adverse or AIDS-defining events during TI. Conclusions: Long-term TI resulted in greater immune deterioration in patients with high viral set points or low CD4 cell counts prior to initiation of suppressive antiretroviral therapy.

Original languageEnglish (US)
Pages (from-to)7-12
Number of pages6
JournalHIV Medicine
Volume6
Issue number1
DOIs
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

HIV
RNA
CD4 Lymphocyte Count
Lipodystrophy
Therapeutics
HIV Infections
Acquired Immunodeficiency Syndrome
Nonparametric Statistics
Viral Load
HIV-1
Demography

Keywords

  • Antiretroviral therapy
  • Chronic HIV
  • Treatment interruption

ASJC Scopus subject areas

  • Virology
  • Medicine(all)
  • Immunology

Cite this

Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA. / Achenbach, Chad J.; Till, M.; Palella, F. J.; Knoll, Maria Deloria; Terp, S. M.; Kalnins, A. U.; Murphy, R. L.

In: HIV Medicine, Vol. 6, No. 1, 01.2005, p. 7-12.

Research output: Contribution to journalArticle

Achenbach, Chad J. ; Till, M. ; Palella, F. J. ; Knoll, Maria Deloria ; Terp, S. M. ; Kalnins, A. U. ; Murphy, R. L. / Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA. In: HIV Medicine. 2005 ; Vol. 6, No. 1. pp. 7-12.
@article{dd45cf9d094c4dec897cc04ae1399d8e,
title = "Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA",
abstract = "Objectives: Evaluation of extended treatment interruption (TI) in chronic HIV infection among patients successfully treated with antiretroviral therapy. Methods: An observational analysis of 25 patients in a prospectively followed cohort with chronic HIV infection, viral loads <500 HIV-1 RNA copies/mL for at least 6 months, and an interruption in therapy of ≥ 28 days duration was carried out. Follow up was divided into 3-month time periods for analysis. The effects of time period, stratification group and stratification group by time period interactions on CD4 counts were tested using a mixed model. Univariate comparisons among patient characteristics and responses were performed using Fisher's exact test or the Wilcoxon rank sum test. Results: At initiation of TI, the median CD4 count was 799 cells/μL. TI duration was a median of 7.1 months. HIV RNA rebounded to a median maximum level of 75 000 copies/mL. Maximum viral rebound was significantly greater in patients who were male, had lipodystrophy and had zenith HIV RNA prior to TI of ≥ 50 000 copies/mL. Lower CD4 cell counts were observed during TI in patients with lipodystrophy, zenith HIV RNA ≥ 50 000 copies/mL, history of AIDS, HIV infection ≥ 5 years and presuppression CD4 count ≤ 350 cells/μL. Patients who reinitiated therapy had shorter TI duration, presuppression CD4 count ≤ 350 cells/μL, previous AIDS diagnosis and lipodystrophy. No patients developed adverse or AIDS-defining events during TI. Conclusions: Long-term TI resulted in greater immune deterioration in patients with high viral set points or low CD4 cell counts prior to initiation of suppressive antiretroviral therapy.",
keywords = "Antiretroviral therapy, Chronic HIV, Treatment interruption",
author = "Achenbach, {Chad J.} and M. Till and Palella, {F. J.} and Knoll, {Maria Deloria} and Terp, {S. M.} and Kalnins, {A. U.} and Murphy, {R. L.}",
year = "2005",
month = "1",
doi = "10.1111/j.1468-1293.2005.00257.x",
language = "English (US)",
volume = "6",
pages = "7--12",
journal = "HIV Medicine",
issn = "1464-2662",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA

AU - Achenbach, Chad J.

AU - Till, M.

AU - Palella, F. J.

AU - Knoll, Maria Deloria

AU - Terp, S. M.

AU - Kalnins, A. U.

AU - Murphy, R. L.

PY - 2005/1

Y1 - 2005/1

N2 - Objectives: Evaluation of extended treatment interruption (TI) in chronic HIV infection among patients successfully treated with antiretroviral therapy. Methods: An observational analysis of 25 patients in a prospectively followed cohort with chronic HIV infection, viral loads <500 HIV-1 RNA copies/mL for at least 6 months, and an interruption in therapy of ≥ 28 days duration was carried out. Follow up was divided into 3-month time periods for analysis. The effects of time period, stratification group and stratification group by time period interactions on CD4 counts were tested using a mixed model. Univariate comparisons among patient characteristics and responses were performed using Fisher's exact test or the Wilcoxon rank sum test. Results: At initiation of TI, the median CD4 count was 799 cells/μL. TI duration was a median of 7.1 months. HIV RNA rebounded to a median maximum level of 75 000 copies/mL. Maximum viral rebound was significantly greater in patients who were male, had lipodystrophy and had zenith HIV RNA prior to TI of ≥ 50 000 copies/mL. Lower CD4 cell counts were observed during TI in patients with lipodystrophy, zenith HIV RNA ≥ 50 000 copies/mL, history of AIDS, HIV infection ≥ 5 years and presuppression CD4 count ≤ 350 cells/μL. Patients who reinitiated therapy had shorter TI duration, presuppression CD4 count ≤ 350 cells/μL, previous AIDS diagnosis and lipodystrophy. No patients developed adverse or AIDS-defining events during TI. Conclusions: Long-term TI resulted in greater immune deterioration in patients with high viral set points or low CD4 cell counts prior to initiation of suppressive antiretroviral therapy.

AB - Objectives: Evaluation of extended treatment interruption (TI) in chronic HIV infection among patients successfully treated with antiretroviral therapy. Methods: An observational analysis of 25 patients in a prospectively followed cohort with chronic HIV infection, viral loads <500 HIV-1 RNA copies/mL for at least 6 months, and an interruption in therapy of ≥ 28 days duration was carried out. Follow up was divided into 3-month time periods for analysis. The effects of time period, stratification group and stratification group by time period interactions on CD4 counts were tested using a mixed model. Univariate comparisons among patient characteristics and responses were performed using Fisher's exact test or the Wilcoxon rank sum test. Results: At initiation of TI, the median CD4 count was 799 cells/μL. TI duration was a median of 7.1 months. HIV RNA rebounded to a median maximum level of 75 000 copies/mL. Maximum viral rebound was significantly greater in patients who were male, had lipodystrophy and had zenith HIV RNA prior to TI of ≥ 50 000 copies/mL. Lower CD4 cell counts were observed during TI in patients with lipodystrophy, zenith HIV RNA ≥ 50 000 copies/mL, history of AIDS, HIV infection ≥ 5 years and presuppression CD4 count ≤ 350 cells/μL. Patients who reinitiated therapy had shorter TI duration, presuppression CD4 count ≤ 350 cells/μL, previous AIDS diagnosis and lipodystrophy. No patients developed adverse or AIDS-defining events during TI. Conclusions: Long-term TI resulted in greater immune deterioration in patients with high viral set points or low CD4 cell counts prior to initiation of suppressive antiretroviral therapy.

KW - Antiretroviral therapy

KW - Chronic HIV

KW - Treatment interruption

UR - http://www.scopus.com/inward/record.url?scp=13944282291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13944282291&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1293.2005.00257.x

DO - 10.1111/j.1468-1293.2005.00257.x

M3 - Article

C2 - 15670246

AN - SCOPUS:13944282291

VL - 6

SP - 7

EP - 12

JO - HIV Medicine

JF - HIV Medicine

SN - 1464-2662

IS - 1

ER -